![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Impact of Treatment Interruption on HIV Reservoirs and
Immunologic Parameters
|
|
|
Reported by Jules Levin
CROI 2018 March 4-6 Boston MS
Katherine E. Clarridge1, Jana Blazkova1, Kevin Einkauf2, Mary Petrone1, Eric W. Refsland1, J. Shawn Justement1, Victoria Shi1, Erin D. Huiting1, Marissa A. Hand1, Catherine A. Seamon 1, Guinevere Q. Lee2, Xu G. Yu2, Susan Moir1, Michael C. Sneller1, Mathias Lichterfeld2, and Tae-Wook Chun1
1Laboratory of Immunoregulation, NIAID, National Institutes of Health, Bethesda, MD, USA; 2Ragon Institute of MGH, MIT, and Harvard, Cambridge and Infectious Disease Division, Brigham and Women's Hospital, Boston, MA, USA
Download the PDF here
![AASDL1](../images%20/032018/032018-3/AASDL1.gif)
![AASDL2](../images%20/032018/032018-3/AASDL2.gif)
![AASDL3](../images%20/032018/032018-3/AASDL3.gif)
![AASDL4](../images%20/032018/032018-3/AASDL4.gif)
![AASDL5](../images%20/032018/032018-3/AASDL5.gif)
![AASDL4](../images%20/032018/032018-3/AASDL4.gif)
![AASDL5](../images%20/032018/032018-3/AASDL5.gif)
![AASDL6](../images%20/032018/032018-3/AASDL6.gif)
![AASDL7](../images%20/032018/032018-3/AASDL7.gif)
![AASDL8](../images%20/032018/032018-3/AASDL8.gif)
![AASDL9](../images%20/032018/032018-3/AASDL9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|